Kobe, Japan

Fumio Hariguchi

This inventor holds 1 USPTO granted patent. Top assignee: Takeda Chemical Industries, Inc.. Active years: 1992.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fumio Hariguchi: Innovator in Protozoal Disease Control

Introduction

Fumio Hariguchi is a notable inventor based in Kobe, Japan. He has made significant contributions to the field of veterinary medicine, particularly in the control of protozoal diseases affecting domestic animals. His innovative approach combines natural plant components with ionophore antibiotics to create effective treatment methods.

Latest Patents

Hariguchi holds a patent for a method aimed at the prophylaxis or treatment of protozoal diseases. This method involves administering a plant component with antiprotozoal activity alongside an ionophore antibiotic. The patent emphasizes that this approach is both safe and economical, providing excellent results in combating protozoal diseases. This innovation is particularly beneficial for the poultry and livestock industries.

Career Highlights

Fumio Hariguchi is associated with Takeda Chemical Industries, Inc., a leading company in the pharmaceutical and biotechnology sectors. His work at Takeda has allowed him to focus on developing solutions that enhance animal health and productivity.

Collaborations

Throughout his career, Hariguchi has collaborated with esteemed colleagues such as Toshimi Matsuno and Tsutomu Okamoto. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Fumio Hariguchi's contributions to the control of protozoal diseases represent a significant advancement in veterinary medicine. His innovative methods not only improve animal health but also support the agricultural industry. His work continues to inspire future innovations in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…